NYSE:ABC

179.98
0.00 (0.00%) 1d
0
Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

Amerisourcebergen Corp (ABC-N) is driving innovation in partnerships with global manufacturers, providers, and pharmacies to enhance product access and efficiency in the healthcare supply chain. As a leader in global sourcing and distribution, they offer a wide range of pharmaceutical and healthcare products, ensuring secure and cost-effective delivery. Their solutions benefit pharmacies, providers, and patients by improving operational efficiency, cost control, growth opportunities, and patient safety. With a focus on knowledge, reach, and partnership, Amerisourcebergen is shaping healthcare delivery for the better.

Consensus
Positive
Valuation
Fair Value
premium

🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Premium members

Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.

TOP PICK

Amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery. Social media mentions are up 200% in the past 24h.

wholesale distributors
BUY
Pays a fine dividend and trades at a decent PE. They do well in times good and bad.
wholesale distributors
DON'T BUY
Looking at seasonality before election cycles, this was the only one that underperformed in the sector. It is a wholesaler between the manufacturer and pharmacies. He prefers McKessen to this name. He doesn't know about the opioids and their potential exposure. It's an inexpensive company, but he would prefer to buy this in an ETF.
wholesale distributors
DON'T BUY
They are essentially the balance sheet for the US pharma industry. They are the distributors in the industry. It is a stock that has really struggled. You think it is good value but really it is dead money.
wholesale distributors
DON'T BUY
It has a good cash flow and steady dividend. The problem is the business drivers are not very good right now. Cost pressures in the industry is causing them to cut costs, which leads to margin erosion. He would look elsewhere.
wholesale distributors
TOP PICK

One of the three major US drug distributors. Partnered with Walgreens to buy drugs from manufacturers in bulk, then sell to pharmacies and hospitals at profit. Trades at a low multiple. The industry has challenges: generic pricing has been soft and declining, but that's stabilizing now to ABC's margins. ABC has the highest exposure among its peers to specialty pharmaceuticals which are growing faster at higher margins. Their contracts are set through 2020. (Analysts' price target $103.87)

wholesale distributors
BUY

This drug distributor controls huge volumes of non-proprietary distribution networks. There is uncertainty in health care generally however. It is very inexpensive here. He would consider buying at these levels.

wholesale distributors
DON'T BUY

He is not a big fan of drug distributors. The technical chart has been whippy. He would prefer to see higher highs on the chart and confirmed by relative strength. The healthcare space is neutral in their valuation. (Analysts’ price target is $105 )

wholesale distributors
COMMENT

CVS Health Corp (CVS-N) vs Walgreen Boots Alliance (WBA-O) or stay out of health care? He prefers Walgreen between the two, due to their Rite Aid acquisition. They feel that a safer option is AmerisourceBergen (ABC-N) as they are more on the distribution side.

wholesale distributors
PAST TOP PICK

(A Top Pick April 4/16. Up 4%.) Part of the fallout from the healthcare situation in the US. Trading at very mid-teen multiples, much less than what the market is trading at. Also, this is partially owned by Walgreens (WBA-Q) who got the contract away from CVS (CVS-N), so there is going to be an extra 40 million prescriptions going to be written that Amerisource is going to take advantage of. He is going to continue to Buy more.

wholesale distributors
TOP PICK

One out of 5 pills we take are coming from this company. A very well-run company with a terrific free cash flow yield of just under 10%. Very profitable. Reasonably cheap, because healthcare has come under pressure. This is closely related to Walgreens (WBA-Q) which he has recommended in the past. Walgreens is their biggest customer. Dividend yield of 1.6%. (Analysts’ price target is $90.)

wholesale distributors
COMMENT

MCK-N vs. ABC-N. He likes both, but prefers Cardinal Health (CAH-N). Those running for election are talking limits of drug prices.

wholesale distributors
COMMENT

A big drug distributor. Part of the problem is drug pricing, and generic pricing has become a bit of a political issue as well. Have a sustainable and growing dividend, but now it is in a situation where even if management gets it all right, there is a huge investor turnover to work through before starting to make your money back. He tends to avoid these because the return over time is not very good.

wholesale distributors
TOP PICK

Inflation was driving their revenues and now has come off a bit. It is a long term hold. Over the counter oncology drugs are slowing and so pricing power is getting weaker. Walgreen has been exercising some warrants and so is diluting the stock. Now they should get back to doing what they are doing. It may do nothing for 2 years.

wholesale distributors
PAST TOP PICK

(BNN had the date as Nov 28/13, but I show Nov 8/13.) (A Top Pick Nov 8/13. Down 0.32%.) A distributor, not a manufacturer of pharmaceuticals. Have Walgreen (WAG-N) and Bootes as their biggest partners. Share price has been a little weak only because they issued warrants to Walgreens and issued long-term debt to buy back shares to offset the warrants. Going to start hitting its earnings growth over 2015-2016.

wholesale distributors
Showing 1 to 15 of 21 entries

Amerisourcebergen Corp(ABC-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Amerisourcebergen Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Amerisourcebergen Corp(ABC-N) Frequently Asked Questions

What is Amerisourcebergen Corp stock symbol?

Amerisourcebergen Corp is a American stock, trading under the symbol ABC-N on the New York Stock Exchange (ABC). It is usually referred to as NYSE:ABC or ABC-N

Is Amerisourcebergen Corp a buy or a sell?

In the last year, there was no coverage of Amerisourcebergen Corp published on Stockchase.

Is Amerisourcebergen Corp a good investment or a top pick?

Amerisourcebergen Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Amerisourcebergen Corp.

Why is Amerisourcebergen Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Amerisourcebergen Corp worth watching?

0 stock analysts on Stockchase covered Amerisourcebergen Corp In the last year. It is a trending stock that is worth watching.

What is Amerisourcebergen Corp stock price?

On 2023-08-29, Amerisourcebergen Corp (ABC-N) stock closed at a price of $179.98.